Cite
HARVARD Citation
Diesinger, T. et al. (2021). A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma. Canadian journal of gastroenterology & hepatology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Diesinger, T. et al. (2021). A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma. Canadian journal of gastroenterology & hepatology. p. . [Online].